C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2004
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224974 7-phenylpyrazolopyridine compounds
11/11/2004	US20040224973 Substituted indoles as alpha-1 agonists
11/11/2004	US20040224971 Substituted azaindole as drugs and enzyme inhibitors
11/11/2004	US20040224970 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
11/11/2004	US20040224964 Corticotropin Releasing factor antagonist as drugs
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224958 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224951 5,6-Fused uracil derivatives as matrix metalloproteinase inhibitors
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	US20040223915 Cytostatic cerium compounds
11/11/2004	DE10318610A1 7-Azaindole und deren Verwendung als Therapeutika 7-azaindoles and their use as therapeutic agents
11/11/2004	CA2524125A1 Antibiotic tetrahydro-.beta.-carboline derivatives
11/11/2004	CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2522430A1 Inhibitors of akt activity
11/11/2004	CA2521951A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
11/11/2004	CA2521924A1 Azabicyclononene derivatives
11/11/2004	CA2521898A1 Diazabicyclononene derivatives
11/11/2004	CA2521158A1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
11/11/2004	CA2520842A1 Cannabinoid receptor ligands and uses thereof
11/10/2004	EP1475380A1 White light emitting compound, white light emission illuminator, and white light emission organic el device
11/10/2004	EP1475379A1 Use of scopine ester derivatives for the synthesis of drugs
11/10/2004	EP1475093A1 Micronized Zolpidem hemitartrate
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474424A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
11/10/2004	EP1474420A1 Quinazoline compounds
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1474135A1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
11/10/2004	EP1017384B1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/10/2004	EP0929544B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545515A 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative
11/10/2004	CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
11/10/2004	CN1174986C Tricyclic benzodiazepines as vasopressin receptor antagonists
11/10/2004	CN1174983C Method for purifying diversine
11/10/2004	CN1174982C Thrombin inhibiting diketopiperazine derivs.
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174980C Imidazole pyridine derivatives capable of inhibiting gastric acid secretion
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/09/2004	US6815546 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815449 An immunosuppressants for treating autoimmune diseases, antiallergic agents, antitumor agents
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/09/2004	US6815439 Pyrrolo(2,3-b)pyridine derivatives as cyclin-dependent kinase inhibitors
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815090 Organic electroluminescence device
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/04/2004	WO2004094429A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004094427A1 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
11/04/2004	WO2004094425A1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094423A1 Processes for producing pyrazoloacridone derivative and intermediate therefor
11/04/2004	WO2004094422A1 Substituted pyrroline kinase inhibitors
11/04/2004	WO2004094421A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004094420A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
11/04/2004	WO2004094419A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
11/04/2004	WO2004094418A1 Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
11/04/2004	WO2004094417A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	WO2004094416A1 7-azaindoles and use thereof as therapeutic agents
11/04/2004	WO2004094415A1 Risperidone monohydrochloride
11/04/2004	WO2004094414A1 Water soluble salts of risperidone
11/04/2004	WO2004094372A2 Compounds useful as serine protease inhibitors
11/04/2004	WO2004093877A1 Vitamin comprising pyroloquinoline quinone and use thereof
11/04/2004	WO2004093873A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004087145A3 Antibacterial agents
11/04/2004	WO2004085436A3 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
11/04/2004	WO2004083215A3 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
11/04/2004	WO2004074812A3 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/04/2004	WO2004074248A3 Isolation and structure of cribrostatin 6
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2004050681A3 Kinase modulators
11/04/2004	WO2004030629A3 Novel neurokinin antagonists and methods of use thereof
11/04/2004	WO2003082867A8 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220271 Fungicidal active compound combinations
11/04/2004	US20040220246 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220213 Zolpidem hemitartrate
11/04/2004	US20040220212 Zolpidem hemitartrate
11/04/2004	US20040220211 Zolpidem hemitartrate
11/04/2004	US20040220210 therapy of insomia, sleep disorders
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220208 Imidazopyridinones as p38 map kinase inhibitors
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220206 anticoagulants; antiinflammatory agents; cardiovascular disorders

1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 646